Abbott Laboratories (ABT)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 03:23PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 202.04B |
| Enterprise Value | 209.57B |
| Trailing P/E | 36.63 |
| Forward P/E | 22.52 |
| PEG Ratio (5 yr expected) | 4.25 |
| Price/Sales (ttm) | 4.99 |
| Price/Book (mrq) | 5.14 |
| Enterprise Value/Revenue | 5.15 |
| Enterprise Value/EBITDA | 20.23 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.72 |
| 52-Week Change 3 | 25.97% |
| S&P500 52-Week Change 3 | 32.96% |
| 52 Week High 3 | 121.64 |
| 52 Week Low 3 | 90.87 |
| 50-Day Moving Average 3 | 113.10 |
| 200-Day Moving Average 3 | 110.25 |
Share Statistics
| Avg Vol (3 month) 3 | 5.89M |
| Avg Vol (10 day) 3 | 4.36M |
| Shares Outstanding 5 | 1.74B |
| Implied Shares Outstanding 6 | 1.75B |
| Float 8 | 1.73B |
| % Held by Insiders 1 | 0.52% |
| % Held by Institutions 1 | 77.51% |
| Shares Short (Sept 30, 2024) 4 | 11.83M |
| Short Ratio (Sept 30, 2024) 4 | 2.44 |
| Short % of Float (Sept 30, 2024) 4 | 0.68% |
| Short % of Shares Outstanding (Sept 30, 2024) 4 | 0.68% |
| Shares Short (prior month Aug 30, 2024) 4 | 12.75M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 2.2 |
| Forward Annual Dividend Yield 4 | 1.89% |
| Trailing Annual Dividend Rate 3 | 2.16 |
| Trailing Annual Dividend Yield 3 | 1.86% |
| 5 Year Average Dividend Yield 4 | 1.64 |
| Payout Ratio 4 | 66.88% |
| Dividend Date 3 | Nov 15, 2024 |
| Ex-Dividend Date 4 | Oct 15, 2024 |
| Last Split Factor 2 | 10000:4798 |
| Last Split Date 3 | Jan 02, 2013 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 13.65% |
| Operating Margin (ttm) | 17.66% |
Management Effectiveness
| Return on Assets (ttm) | 6.26% |
| Return on Equity (ttm) | 14.44% |
Income Statement
| Revenue (ttm) | 40.73B |
| Revenue Per Share (ttm) | 23.40 |
| Quarterly Revenue Growth (yoy) | 4.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 10.57B |
| Net Income Avi to Common (ttm) | 5.54B |
| Diluted EPS (ttm) | 3.17 |
| Quarterly Earnings Growth (yoy) | -5.30% |
Balance Sheet
| Total Cash (mrq) | 7.22B |
| Total Cash Per Share (mrq) | 4.15 |
| Total Debt (mrq) | 14.84B |
| Total Debt/Equity (mrq) | 37.53% |
| Current Ratio (mrq) | 1.68 |
| Book Value Per Share (mrq) | 22.60 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 7.9B |
| Levered Free Cash Flow (ttm) | 5.39B |
© 2024 Yahoo. All rights reserved.